Mercury Laboratories P/B Ratio
Mercury Laboratories (MERCURYLAB) P/B ratio is 1.66 (Moderate), book value per share ₹540.00 vs Healthcare average P/B of -1.0 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see MERCURYLAB stock overview.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
MERCURYLAB P/B Ratio — Valuation Insights & Book Value Analysis
Mercury Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 1.66 (Moderate).
- Trading at premium to sector average PB of -1.0
Mercury Laboratories P/B Ratio Historical Trend
MERCURYLAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Browse Mercury Laboratories annual reports for revenue, profit, balance sheet and cash flow data.
MERCURYLAB Historical P/B Ratio — Book Value Per Share & Year-End Price
Mercury Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.5 | ₹540.0 | ₹811.20 | ₹54 | Moderate |
| 2024 | 1.76 | ₹510.0 | ₹896.00 | ₹51 | Moderate |
| 2023 | 2.24 | ₹460.0 | ₹1029.60 | ₹46 | Moderate |
| 2022 | 1.95 | ₹400.0 | ₹779.00 | ₹40 | Moderate |
| 2021 | 1.9 | ₹370.0 | ₹701.35 | ₹37 | Moderate |
MERCURYLAB vs Healthcare Peers — P/B Ratio Comparison
Mercury Laboratories P/B 1.66 vs Healthcare average -1.0, median 0.62 — range -36.63–1.05.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -36.63 | ₹28 | Low |
| Sun Pharma Advanced Rese… | SPARC | -13.83 | ₹4,744 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.35 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.09 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |